Two Sigma Investments’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-23,800
Closed -$1.52M 3700
2018
Q4
$1.52M Sell
23,800
-61,000
-72% -$4.5M 0.01% 1389
2018
Q3
$7.59M Sell
84,800
-213,800
-72% -$18.9M 0.02% 762
2018
Q2
$23.7M Buy
298,600
+227,600
+321% +$18.9M 0.07% 362
2018
Q1
$6.33M Buy
+71,000
New +$6.82M 0.02% 822
2017
Q4
Sell
-26,000
Closed -$3.79M 3677
2017
Q3
$3.79M Buy
26,000
+10,000
+63% +$1.36M 0.01% 940
2017
Q2
$2.08M Buy
16,000
+8,000
+100% +$980K 0.01% 1394
2017
Q1
$995K Sell
8,000
-7,000
-47% -$838K ﹤0.01% 1936
2016
Q4
$1.74M Sell
15,000
-27,000
-64% -$3.01M 0.01% 1601
2016
Q3
$4.39M Sell
42,000
-3,700
-8% -$400K 0.02% 957
2016
Q2
$4.51M Buy
45,700
+24,700
+118% +$2.55M 0.02% 812
2016
Q1
$2.1M Sell
21,000
-22,000
-51% -$2.27M 0.01% 1156
2015
Q4
$5.15M Buy
43,000
+39,000
+975% +$4.51M 0.02% 655
2015
Q3
$433K Sell
4,000
-13,000
-76% -$1.61M ﹤0.01% 1616
2015
Q2
$1.97M Buy
+17,000
New +$1.94M 0.01% 1209

Other funds holding CELG

Two Sigma Investments's CELG Position: Q4 2019 in Review

Two Sigma Investments sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 741,969 shares — an estimated $73.7M sold.

Two Sigma Investments first reported a position in CELG in Q2 2013 and held it in 20 quarters. The position peaked at $183M in Q2 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Two Sigma Investments reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Two Sigma Investments sold 741,969 Celgene Corp shares in Q4 2019, an estimated $73.7M.
  • Two Sigma Investments first reported a position in Celgene Corp in Q2 2013 and held it in 20 quarters.
  • Two Sigma Investments's Celgene Corp position peaked at $183M in Q2 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Two Sigma Investments's 13F filing for Q4 2019, filed 14 Feb 2020.